Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Innodem Neurosciences is a pioneering Montreal-based company focused on developing innovative eye-tracking solutions for the early detection and management of neurological diseases. By leveraging artificial intelligence and advanced eye-tracking technology, Innodem aims to provide clinicians with objective, accessible, and cost-effective tools to improve patient outcomes. Their technology holds promise for a wide range of neurological conditions, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Headquarters serves as the central hub for research and development, executive leadership, and administrative operations.
Located in a modern office building in downtown Montreal, providing easy access to universities, research institutions, and potential partners.
Likely fosters a collaborative and innovative work environment focused on scientific discovery and technological advancement.
The Montreal headquarters signifies Innodem's commitment to contributing to the Canadian healthcare and technology ecosystem.
While headquartered in Montreal, Innodem Neurosciences aims to establish a global presence through partnerships with pharmaceutical companies and healthcare providers. Their technology is intended for deployment worldwide to improve neurological disease management globally.
550 Sherbrooke St W
Montreal
Quebec
Canada
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Innodem Neurosciences' leadership includes:
Innodem Neurosciences has been backed by several prominent investors over the years, including:
Based on available information, there haven't been significant public announcements regarding executive hires or exits at Innodem Neurosciences in the last 12 months. This could indicate stability within the executive leadership team.
Discover the tools Innodem Neurosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The likely email format for Innodem Neurosciences employees follows a pattern of first initial and last name followed by the company domain. This is a common practice in many organizations.
[first_initial][last]@innodemneurosciences.com
Format
jreaves@innodemneurosciences.com
Example
80%
Success rate
No recent news available.
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Innodem Neurosciences, are just a search away.